Dec, 10th 2020 – Canada has approved the Pfizer-BioNtech coronavirus vaccine following confirmation by the agency that it has met its stringent safety, efficacy and quality requirements. The Canadian government has now purchased 20 million doses of the vaccine which are enough to inoculate 10 million people with the option to buy 56 million more.
senior medical adviser at Canada’s health department Supriya Sharma said, “We are not in a race with any other regulator. What we are trying to do is beat this virus. We expedited the review, but we did not compromise in terms of the safety, efficacy and quality.”
On Wednesday, a spokeswoman for Pfizer’s Canadian unit said that Pfizer will supply up to 76 million dozes of the vaccine. In total, the Canadian government has purchased 20 million doses of the vaccine enough for 10 million people with an option of buying 56 million more.
In a statement, Health Canada said, “Today, Canada reached a critical milestone in its fight against Covid-19 with the authorization of the first Covid-19 vaccine.”
UK was the first country to approve the vaccine with the first patient to receive the jab being a 90 turning 91 years old woman. Margret Keenan, the recipient, received the jab at University Hospital Coventry and expressed her joy saying she is privileged to be the first person to receive the jab.
She said, “I feel so privileged to be the first person vaccinated against COVID-19. It’s the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year.“
Companies behind the first covid-19 vaccine are working to meet production targets as more countries move to authorize it. Pfizer and BioNTech have presold around 600 million doses access the world but have produced just a fraction of the number so far. They say that they will manufacture 50 million more doses by the end of 2020, a goal they have already hit and by end of 2012 hit 1.3 billion.
Canada is the second country to authorize the vaccine after the UK rolled it out on Tuesday this week.